The trading price of Immuneering Corp (NASDAQ:IMRX) closed higher on Monday, July 07, and closing at $4.05, 17.39% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $3.43 and $4.1698. In examining the 52-week price action we see that the stock hit a 52-week high of $3.87 and a 52-week low of $1.00. Over the past month, the stock has gained 106.63% in value.
Immuneering Corp, whose market valuation is $145.74 million at the time of this writing, is expected to release its quarterly earnings report on 2025-May-05. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest IMRX has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 50% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned IMRX a recommendation rating is 3. Out of them, 0 rate it a Hold, while 3 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Immuneering Corp (IMRX) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that IMRX’s price is currently 47.30% off the SMA20 and 104.32% off the SMA50. The RSI metric on the 14-day chart is currently showing 74.12, and weekly volatility stands at 13.01%. When measured over the past 30 days, the indicator reaches 16.93%. Immuneering Corp (NASDAQ:IMRX)’s beta value is currently sitting at 0.37. With analysts defining $3-$41 as the low and high price targets, we arrive at a consensus price target of $13 for the trailing 12-month period. The current price is about 25.93% off the estimated low and -912.35% off the forecast high, based on this estimate. Investors will be thrilled if IMRX’s share price rises to $13, which is the median consensus price. At that level, IMRX’s share price would be -220.99% below current price.
To see how Immuneering Corp stock has been performing in comparison to its peers in the industry, here are the numbers: IMRX stock’s performance was 17.39% in the latest trading, and 84.09% in the past year.
An evaluation of the daily trading volume of Immuneering Corp (NASDAQ:IMRX) indicates that the 3-month average is 1.09 million. However, this figure has increased over the past 10 days to an average of 1.52.
Currently, records show that 35.99 million of the company’s shares remain outstanding. The insiders hold 28.26% of outstanding shares, whereas institutions hold 12.50%. The stats also highlight that short interest as of 2025-06-13, stood at 0.89 million shares, resulting in a short ratio of 3.13 at that time. From this, we can conclude that short interest is 325.00 of the company’s total outstanding shares. It is noteworthy that short shares in June were up slightly from the previous month’s figure, which was 0.66 million. However, since the stock’s price has seen 271.56% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
